Oliveira, LMA; Prasad, N; Lynfield, R; Ip, M; Sanou, S; Neves, FPG; Wilder-Smith, A; Soeters, HM; Le Doare, K; Preziosi, M-P
(2025)
WHO defeating meningitis symposium, 3rd international symposium on Streptococcus agalactiae disease (ISSAD) in Rio de Janeiro, Brazil: State-of-the-art overview of S. agalactiae meningitis.
VACCINE, 52.
p. 126895.
ISSN 0264-410X
https://doi.org/10.1016/j.vaccine.2025.126895
SGUL Authors: Le Doare, Kirsty
![]() |
Microsoft Word (.docx)
Accepted Version
Restricted to Repository staff only until 22 February 2026. Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (181kB) |
Abstract
A World Health Organization (WHO) Defeating Meningitis Symposium took place as part of the 3rd International Symposium on Streptococcus agalactiae disease (ISSAD) conference which was held in Rio de Janeiro, Brazil, from October 16–18, 2023. The symposium highlighted WHO's Defeating meningitis by 2030 global road map focusing on Group B Streptococcus (GBS) meningitis and provided an overview of the meningitis burden and main challenges faced to tackle the disease across the Americas, Africa, and Asia.
Item Type: | Article |
---|---|
Additional Information: | © 2025. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Keywords: | Group B Streptococcus, Meningitis, WHO defeating meningitis by 2030 global road map |
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: | VACCINE |
ISSN: | 0264-410X |
Language: | en |
Publisher License: | Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0 |
URI: | https://openaccess.sgul.ac.uk/id/eprint/117429 |
Publisher's version: | https://doi.org/10.1016/j.vaccine.2025.126895 |
Statistics
Actions (login required)
![]() |
Edit Item |